Retatrutide Clinical Trials & Results Last updated: August 1, 2026 Retatrutide (LY3437943) is Eli Lilly's investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors
Take it at night, at least 2 hours after dinner, to support liver detoxification, cellular repair, and better sleep quality
Mounjaro commonly causes gastrointestinal side effects (nausea, vomiting, diarrhoea) and can modestly increase heart rate, whilst beta blockers reduce heart rateeffects typically balance without clinical concern
Biomed Pharmacother, 2021
Can I Get At-Home Glutathione IV Treatments
Purity and Quality Standards AVPs GLP-3 RT is produced and verified to a high purity standard, with batch testing used to confirm consistency before a vial reaches a research setting